Abstract: Evidence has accumulated that malignancy arises from maturation arrest of stem cells -rather than the dedifferentiation of somatic cells. To support this notion, stem cells in contrast to somatic cells are long lived cells and thus may become the subject of accumulating mutations that are crucial for the initiation/progression of cancer. More importantly they may maintain these mutations and pass them to daughter stem cells. Cancer stem cells (CSC) that derive from transformed normal stem cells (NSC) are responsible not only for tumor initiation, but also for its re-growth and metastasis. Accumulating evidence also indicates that adult tissues may contain a population of very small embryonic like (VSEL) stem cells that may give rise to some very immature tumors e.g., pediatric sarcomas. Similar molecular mechanisms operating in NSC and CSC regulate resistance to radio-chemotherapy and promote migration/metastasis. Thus, by studying the biology of NSC we can learn more about cancer.
Introduction
Evidence supports that many if not all cancers depend on a small population of cancer stem cells (CSC) for their continuous growth and expansion. The concept of CSC has been postulated in the past by several investigators [1] [2] [3] [4] , and recently experimentally documented for human leukemia [5, 6] , brain [7] , breast [8] , prostate [9, 10] and lung cancers [11] . In support of this notion, stem cells are long lived cells and thus become the subject of accumulating mutations that are crucial for the initiation of tumor. Therefore, mutations that occur in normal stem cells (NSC) accumulate in these cells and finally may lead to malignant transformation and clonal expansion of CSC and tumor initiation [12] [13] [14] [15] . Since CSC exist in a quiescent state similar to NSC, they possess efficient DNA repair mechanisms, high activity of telomerase and may be relatively resistant to radio-chemotherapy. It is widely accepted that CSC represent in a growing tumor, a subpopulation of malignant cells, which are capable of re-growing the tumor after unsuccessful treatment and initiate metastases [15] . Thus, development of effective therapies specifically targeting CSC may become a promising therapeutic option to fight cancer. Moreover, several mechanisms that are involved in self renewal and trafficking of NSC are also involved in expansion and metastasis of CSC [16] .
Similarities between NSC and CSC
NSC and CSC share many characteristics. First, their capacity for self-renewal renders them essentially immortal. Second, both types of cells possess long telomeres, high activity of telomerase and high expression of ABC transporters (efflux pump) that are responsible for their relative resistance to certain types of cytostatics. They also secrete several growth factors, cytokines and angiopoietic factors -and thus show a predisposition for autocrine growth and stimulation of angiogenesis. At the molecular level several similar pathways are involved in their self renewal/proliferation (Wnt, Sonic Hedhehog and Notch signaling, Polycomb genes -Bmi-1, EZH2). NSC and CSC respond to similar motomorphogens such as SDF-1 or hepatocyte growth factor/scatter factor (HGF/SF) explaining why these factors may regulate the trafficking of normal SC during development/regeneration and promote metastasis of corresponding CSC [17] . Finally NSC and CSC express several similar surface receptors (e.g., CXCR4, Sca-1, CD133, α6 integrin, ckit, c-met, LIF-R). Therefore similar markers may be employed to sort NSC from normal tissues and CSC from malignant transformed tissues. Table 1 summarizes the milestones that lead to the concept that cancer is a stem cell disorder which originates in the compartment of NSC. Accordingly, almost 150 years ago, Vrichow and Connheim proposed that adult tissues contain dormant embryonic remnants "lost" during developmental organogenesis and that this population of very primitive, embryonic like stem cells may give rise to malignancies [1, 12, 14] . The malignant transformation of dormant embryonic stem cell-like cells closely corresponds with the development of some rare tumors (e.g., teratomas) that are usually encountered in younger patients [2] . Recently we identified a population of stem cells at the single cell level that display a similar morphology and express markers characteristic for early embryonic stem cells (Figure 1 ). These cells could support Virchow's concept of a embryonic origin of cancer. We named these cells identified in adult tissues very small embryonic-like (VSEL) stem cells. We hypothesize that these cells may give rise to some pediatric sarcomas [16, 18] . In the past 20 years, several other investigators revisited the idea that cancer may originate in the compartment of stem/progenitor cells (Table 1) . Stem cell origin of malignancies was recently proven in a model of human leukemias, where a very small population of leukemic cells was able to establish leukemia in immunodeficient mice [5, 6] . Similarly, it was also shown that a small population of CD133 positive cells from growing human brain tumors was able to establish tumors in immunodeficient mice [7] . CD34 + Sca-1 + CD45 − cells isolated from murine bronchial epithelium were recently found to be the origin of lung adenocarcinomas [11] , while Sca-1 + CD45 − cells are the origin of murine prostate cancer [9, 10] and Sca-1 + , CD44 + ,CD24 − cells give rise to murine breast cancer [19] . Figure 2 shows the potential origin of CSC. Since several "mutagenetic hits" over a relatively short period of time are required to immortalize and transform short living somatic cells into CSC, this scenario of cancer development is rather unlikely. On the other hand increasingly more evidence has accumulated indicating that adult tissues contain different types of NSC which could be the source of transformed CSC and Figure 2 shows that there are two potential major sources of CSC. The first source are NSC specific for different organs that reside in various organ systems e.g., in the skin hair bulge region, the basal layer of the epidermis [20] [21] [22] , the intestine and stomach epithelium at the bottom of the crypts [23] [24] [25] [26] , in the bone marrow in hematopoietic niches, in the brain in the hypocampus, subventricular region and olphactory bulb [27] [28] [29] [30] [31] [32] [33] [34] [35] , in the bronchial epithelium on the bronocho-alveolar transition [11] , in the mammary gland in terminal end buds [36, 37] and in the prostate in the proximal prostatic ducts [10] . All of these NSC may accumulate mutations over time and initiate malignancies. On the other hand evidence suggests that adult tissues (e.g., bone marrow) may contain a population of non-hematopoietic stem cells that we have initially identified and described as tissue committed stem cells (TSCS) [38] [39] [40] . Our recent research demonstrated that these cells express a similar morphology and markers of embryonic stem cells and as mentioned above we renamed these cells as very small embryonic-like (VSEL) stem cells (Figure 1) .
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Origin of CSC for the developing tumor
By employing multiparameter sorting, we identified in murine BM a homogenous population of rare (∼0. It is also significantly diminished in short living DBA/2J mice as compared to long living B6 animals [38] . In vitro these cells strongly respond to various motomorphogens such as stromal derived factor-1 (SDF-1) and hepatocyte growth factor/scatter factor (HGF/SF) and express the corresponding receptors CXCR4 and c-met respectively. Currently, by employing the appropriate animal models (e.g., stroke, heart infarct) we are testing a potential contribution of these cells towards regeneration of damaged tissues and organs in vivo as well as their role in development of tumors. The presence of aforementioned TCSC or VSELs in the bone marrow (BM) may also explain the contribution of BM-derived cells to tissue organ regeneration [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] . Thus the heterogeneity of BM-derived stem cells [43] as well as the phenomenon of cell fusion [55, 56] [57] we postulate that these cells may be mobilized into peripheral blood and home to the tissues damaged for example by chronic inflammation. If these cells incorporate at the "wrong time," and in the "wrong place," they may contribute to the origin of a CSC instead of regenerating the damaged organ,. This possibility has been recently demonstrated for gastric cancer [58] and intestinal adenocarcinomas [Dr. Ed Scott personal communication]. This scenario strongly links chronic inflammation/tissue injury/irradiation and the development of some tumors. Although it is well known that BM is a source of circulating endothelial stem cells that play a crucial role in subsequent tumor vascularization [41] .
There are still some pitfalls of explaining cancer origins entirely as a stem cell disorder. First, dedifferentiated somatic cells may acquire stem cell markers giving a false impression that they originate from normal stem cells. Cancer stem cells might be derived from more committed progenitors by genetic or epigenetic changes that confer self-renewal ability. This situation is very common in more differentiated leukemias and lymphomas [60] [61] [62] . Furthermore, no experiment supporting stem cell origin of cancer at the single cell level has been demonstrated. Finally, the possibility exists that more differentiated cells rendered immortal by mutations may dedifferentiate and become CSC in certain situations. This scenario may be more common in those patients who have a family history of cancer, who carry predisposing inborn mutations as well as chromosomal abnormalities.
Major Problems with Cancer Therapies explained by a stem cell origin of cancer
There are two major problems responsible for cancer treatment failure . The first problem is the resistance of CSC to radio-chemotherapy and the second one is CSC propensity to metastasize. Both of these can be explained by the fact that CSC originate in the compartment of NSC. Accordingly, CSC are similar to NSC by possessing efficient DNA repair mechanisms and highly expressing ABC transporters making CSC relatively resistant to treatment. On the other hand, metastasis of CSC could be envisioned as a pathological image of the migration of NSC which takes place during normal development and regeneration. To support this notion, NSC and VSELs could be mobilized into peripheral blood from stem cell niches (e.g., in bone marrow) during organ injuries and subsequently circulate in blood to regenerate damaged tissues [16, [38] [39] [40] [41] [42] [43] [44] [45] . As mentioned above, evidence has accumulated supporting that if circulating NSC or VSELs are incorporated at the wrong time, in the wrong place and exposed to a damaged environment, they may undergo malignant transformation with time [58] . The observed increase in cancer incidence associated with chronic injury strongly supports this model of cancer as a continuous state of repair. Thus we can envision that carcinogenesis proceeds by misappropriating homeostatic mechanisms that govern tissue repair and stem cell self-renewal.
Furthermore, recent accumulated evidence indicates that the α-chemokine receptor CXCR4 that is expressed on embryonic stem cells and NSC for different organs/tissues is also highly expressed on several tumors derived from these cells ( Table 2 ). This implies that the SDF-1-CXCR4 axis may influence the biology of cancer while playing a pivotal role in directing the metastasis of CXCR4 + tumor cells. These cells are chemoattracted to damaged organs that highly express its specific ligand (e.g., lymph nodes, lungs, liver, or bones), α-chemokine stromal derived factor-1 (SDF-1). Supporting this notion, it has been recently reported that several CXCR4
+ cancers (e.g., breast-, ovarian-, prostatecancers, as well as rhabdomyosarcoma, and neuroblastoma) metastasize to bones and lymph nodes from the bloodstream in an SDF-1-dependent manner [63] [64] [65] . The involvement of SDF-1 seems to be crucial for metastasis of several CSC; however, other motomorphogens are involved in this process as well. Table 2 NSC could be the origin of CSC for different tumors. Some of these tumors may also originate as we hypothesize from VSEL stem cells. Both NSC and CSC express CXCR4 and c-met receptors and respond by chemotaxis to SDF-1 and HGF/SF.
Developmental motomorphogens as pivotal pro-metastatic factors -damaged organ/tissues chemoattract both NSC and CSC
As mentioned above, evidence has accumulated that SDF-1 and several other motomorphogens such as HGF/SF are important chemoattractants/pro-metastatic factors for tumor cells (Figure 3 ). To support this notion both NSC (including VSELs) and CSC express on their surface the corresponding receptors such as CXCR4 and c-met. Interestingly, promoters of the genes that encode these factors and receptors contain binding sites for hypoxia inducible factor 1α (HIF-1α).
The HIF-1α dependent regulation of CXCR4-SDF-1 and c-met-HGF/SF axes has several important consequences. Since tissue damage results in reduced oxygen supply and hypoxia, these conditions such as chronic inflammation or tissue/organ injuries create an environment that chemoattracts circulating NSC (including VSELs) for regeneration/organ repair [19, [66] [67] [68] . However, similar conditions may chemoattract metastasizing CSC. This explains an obvious link between inflammation, cancer development and cancer spread. On the other hand, since radio-chemotherapy also upregulates the expression of SDF-1 and HGF/SF in tissues (Figure 3) , one of the unwanted side-effects of radio-chemotherapy is generation of a prometastatic environment for CSC in various organs. This promotes the spread of cancer cells that survived radio-chemotherapy to the organs that highly express these motomorphogens (Figure 3 ). Finally circulating cells may not only initiate but also contribute to tumor growth. Thus a tumor is a "wound that never heals" and may contain both cancer and chemoattracted normal stem cells. The more identified population of NSC that are chemnoattracted by tumors are circulating endothelial stem cells [69, 70] and stroma elements [71] .
Implications for future investigations
It is obvious that by studying the biology of NSC we learn more about the biology of CSC. Since CSC are responsible for tumor re-growth after radiochemotherapy and tumor metastasis, there is a need to develop efficient strategies to target these cells.
The SDF-1-CXCR4 and HGF/SF-c-met axes have emerged as important regulators of trafficking normal-and malignant SC, which means that they are potential targets for various therapeutic interventions. Small-molecular inhibitors of CXCR4 such as T140 and AMD 3100, modified recombinant SDF-1 or HGF/SF, and blocking antibodies against CXCR4 are examples of promising compounds [72, 73] . RNA-mediated interference (RNAi) could potentially act as downregulators for the expression of CXCR4 and cmet in target cells [74] . Similarly, downregulation of HIF-1α by a siRNA strategy may lead to downregulation of the expression of SDF-1 and HGF/SF in various tissues, and consequently inhibit the spreading of CXCR4
+ and c-met + tumor cells [75, 76] . Recently, a small molecular inhibitor of transcriptional co-activation for HIF-1gα, called chetomin has been identified. Interestingly the systemic administration of chetomin inhibited hy- poxia inducible transcription within tumors and inhibited tumor growth in mice [75] .
There is no doubt that new, more efficient, and powerful compounds that are free from side-effects will emerge with the ability to control the radio-chemoresistance and metastatic behavior of CSC. New drugs will also be developed to target the population of CSC specifically. Identification of VSELs in adult tissues also opens new areas of investigation to elucidate how these cells contribute to the development of poorly differentiated tumors.
Conclusions
Evidence has accumulated that cancer originates in the stem cell compartment because long living CSC collect mutations and pass them to their progeny. Cancer may originate from transformed NSC that reside in organs/tissues or originate from stem cells chemoattracted from other sites such as bone marrow. Our recent research demonstrates that very small embryonic-like (VSEL) stem cells may persist beyond embryogenesis and such cells may exist in adult bone marrow and perhaps in other organs and tissues. These cells may give rise to poorly differentiated tumors. Furthermore, metastasis of cancer stem cells is a pathological image of the processes that are involved in developmental migration and circulation of NSC. Therefore both CXCR4-SDF-1 and HGF/SF-c-met axes regulate the metastasis of cancer stem cells and motility of normal stem cells. Studying the biology of normal stem cells may help us to better understand the biology of cancer, and explain its resistance to radio-chemotherapy, the ability for unlimited proliferation and establishment of distant metastases.
